Bone Index Receives FDA 510(k) Clearance for the Bindex® Point-of-care Instrument to Help Physicians in Diagnosing Osteoporosis
Submitted by kBLASTER Team on
by PR Newswire
Bone Index Ltd., one of Europe's top new manufacturers of medical devices, has received 510(k) clearance from the Food and Drug Administration (FDA) for the Bindex® point-of-care instrument to help in osteoporosis diagnosis.
Osteoporosis, a very underdiagnosed disease, is responsible for two million broken bones every year in the USA. These fractures translate into costs totaling about 19 billion dollars. Experts forecast that by 2025, the costs due to fractures will rise to 25.3 billion...